1. Home
  2. TPH vs NUVB Comparison

TPH vs NUVB Comparison

Compare TPH & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tri Pointe Homes Inc.

TPH

Tri Pointe Homes Inc.

HOLD

Current Price

$35.34

Market Cap

2.8B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$8.05

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPH
NUVB
Founded
2009
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TPH
NUVB
Price
$35.34
$8.05
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
$41.40
$10.56
AVG Volume (30 Days)
866.1K
5.5M
Earning Date
02-17-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.42
N/A
Revenue
$3,751,941,000.00
$26,748,000.00
Revenue This Year
N/A
$609.55
Revenue Next Year
N/A
$197.91
P/E Ratio
$9.53
N/A
Revenue Growth
N/A
1137.19
52 Week Low
$27.90
$1.54
52 Week High
$38.96
$9.75

Technical Indicators

Market Signals
Indicator
TPH
NUVB
Relative Strength Index (RSI) 67.94 46.68
Support Level $30.51 $8.04
Resistance Level $32.26 $9.10
Average True Range (ATR) 0.88 0.45
MACD 0.20 -0.21
Stochastic Oscillator 95.97 5.52

Price Performance

Historical Comparison
TPH
NUVB

About TPH Tri Pointe Homes Inc.

Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: